State-specific availability of specific medication types may vary based on state pharmacy regulations and the clinical provider's determination - confirm with Omzo's support team whether the program you're interested in is currently available in your state
It is possible that more potent GLP-1 drugs, and triple-receptor agonists will achieve a greater degree of weight loss and extend the benefit to lower risk people in the future

GLP-1 is an incretin hormone that regulates blood glucose by stimulating insulin secretion and suppressing glucagon in a glucose-dependent manner GLP-1 secretion is triggered by nutrients (carbohydrates, fats, proteins) and dietary fibre, not by plain water consumption Water promotes satiety through gastric distension rather than hormonal mechanisms involving GLP-1 pathways Evidence-based approaches to support GLP-1 include increasing dietary fibre, consuming adequate protein, and choosing lower glycaemic index foods GLP-1 receptor agonists are NICE-approved medications for type 2 diabetes when other treatments have not achieved glycaemic targets Table of Contents Understanding GLP-1 and Its Role in Blood Sugar Control Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced primarily by specialised L-cells in the distal small intestine and colon
Our guide on foods to eat while on GLP-1 medications provides detailed dietary guidance
Prescribing Information: Saxenda (liraglutide) injection, for subcutaneous use
Exp Neurol 161:115126 Vereczki V, Martin E, Rosenthal RE, Hof PR, Hoffman GE, Fiskum G (2006) Normoxic resuscitation after cardiac arrest protects against hippocampal oxidative stress, metabolic dysfunction, and neuronal death